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Open access under the ElLesion development in tegumentary leishmaniasis is markedly inﬂuenced by the inoculation site and the
type and number of injected infective forms. This and the yet unclear contribution of Th2 cytokines as
susceptibility factors to Leishmania amazonensis infection prompted us to investigate the roles of IL-4,
IL-13 and IL-10 on C57BL/6 and BALB/c mice infected in the footpad (paw) or rump with low-dose L. ama-
zonensis puriﬁed-metacyclics. Wild-type (WT) mice of either strain developed, in the rump, a single large
ulcerated lesion whereas paw lesions never ulcerated and were much smaller in C57BL/6 than in BALB/c
mice. However, rump-inoculated IL-4-deﬁcient (IL-4/) C57BL/6 mice did not develop any visible lesions
although parasites remained in the dermis and lymph nodes, even after systemic IL-10-receptor blocking.
By comparison, all IL-4/ BALB/c mice developed rump ulcers. Strikingly, only 30% of rump-infected
IL-4Ra/ BALB/c mice developed lesions. IL-4/mice had higher IFN-c and lower IL-10 and IL-13 levels
than WT mice. Paw-infected IL-4Ra/ BALB/c mice developed minimal paw lesions. While other factors
contributing to L. amazonensis susceptibility cannot be discounted, our results indicate that absent signal-
ling by IL-4 or by IL-4/IL-13 have more intense attenuating effects on rump than on paw lesions but do
not eradicate parasitism.
 2011 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
In Europe, Africa, and Asia cutaneous leishmaniasis is most com-
monly caused by the protozoan Leishmania major, whereas in the
Americas the disease is most often caused by Leishmania mexicana,
Leishmania braziliensis or Leishmania amazonensis. In rare cases this
last species can also cause diffuse cutaneous leishmaniasis in
humans.
Mouse models of L. major infection have been extensively
studied. Certain mouse strains (e.g. BALB/c, DBA/2, or SWR/J)
develop progressively larger lesions with heavy parasite burdens.
In contrast to these susceptible strains, mice of resistant strains
(e.g. C57BL/6, C3H, CBA) develop small self-curing lesions with
few surviving parasites at the inoculation site (Handman, 1999;
Sacks and Noben-Trauth, 2002).
However, experimental infections of mice by L. amazonensis
differ in many aspects from those caused by L. major. Most mouse
strains develop at the inoculation site of L. amazonensis a non-heal-
ing lesion, whose size and progression characterize a susceptibility
pattern that may be quite distinct from the one observed in L. major
infection (Osorio y Fortea et al., 2007; Pereira and Alves, 2008;Drive – CRC, Room 3E-3224,
rdo).
sevier OA license.Silveira et al., 2009). Indeed, when L. amazonensis is injected in the
usual L. major-resistant mouse strains, the infection is not self-
curing, causes lesions of varying severity, and is not accompanied
by polarized Th1 cytokine responses. After L. amazonensis infection
in the footpad, C57BL/6 mice develop a persistent non-healing le-
sion, albeit much smaller than observed in similarly infected
BALB/cmice. This partial susceptibility of C57BL/6mice is associated
with lower IFN-c production rather than enhanced IL-4 synthesis
(Afonso and Scott, 1993; Jones et al., 2000). Furthermore, dominant
Th2-type responses are seldom seen in L. amazonensis-susceptible
mouse strains (Afonso and Scott, 1993; Lemos de Souza et al., 2000).
In addition, effective control of L. amazonensis progression was
neither observed in IL-10/ C57BL/6 mice, in spite of a vigorous
Th1 response (Jones et al., 2002), nor in IL-10/ BALB/c mice
(Padigel et al., 2003), although in both models the parasite load
was smaller than in their respective wild-type (WT) controls. These
results suggest that IL-4 and/or IL-13 would have a major role in
susceptibility to L. amazonensis.
The relative weight of IL-4 as susceptibility factor to L. amazon-
ensis depends on the mouse strain under study: IL-4/ mice on a
C57BL/6 background were no more resistant to footpad infections
than the WT controls (Jones et al., 2000), whereas IL-4/ BALB/c
mice developed smaller lesions than their WT counterparts
(Guimaraes et al., 2006; Satoskar et al., 1997). The contribution of
IL-13 to susceptibility to New World cutaneous leishmaniasis has
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amastigotes. A comparative study among IL-13/, IL-4/ IL-13/,
and WT mice (all on a C57Bl/6 X 129sv/EV background) led to the
conclusion that IL-13 was not involved in mediating susceptibility
to L. mexicana (Sosa et al., 2001). However, other research groups
have found a distinctive role for IL-13 as compared to IL-4, in deter-
mining susceptibility of C57Bl/6 X 129sv/EV mice to L. mexicana
(Alexander et al., 2002). The contrasting results between these
two studies can be ascribed to the longer follow-up of infection in
the last one. Reduction of the lesion size in IL-13/ mice became
apparent around 14 weeks after infection with 5  106 amastigotes
or much earlier when the inoculum was reduced to 2  105. A dis-
ease exacerbating role for IL-13 as well as IL-4 was also shown
when L. mexicana infections were compared in IL-4/, IL-4Ra/,
and WT control mice on a BALB/c background (Alexander et al.,
2002).
As for L. amazonensis infection, follow-up experiments of 8–
12 weeks were reported in comparison with data on L. mexicana
infections (McMahon-Pratt and Alexander, 2004). Inocula of 106
L. amazonensis amastigotes were injected into the base of the tail
or into the footpads of IL-4/ and IL-4Ra/mice. The results indi-
cate that the role of IL-4 on susceptibility to L. amazonensis de-
pends on the inoculation site. Absence of IL-4 had no effect on
early lesion progression of paw-infected C57BL/6 WT mice. In con-
trast, paw-inoculated IL-4/ and IL-4Ra/ BALB/c mice both had
much smaller lesions than the corresponding WT controls.
Taken together these studies call attention to the importance of
the observation period length, the site of infection, and the number
of inoculated parasites as variables affecting susceptibility to
infection. In addition to these, the developmental stage of the
sinjected parasites imparts on the course of infection. In most stud-
ies a great number of stationary-phase L. amazonensispromastigotes
were inoculated in the footpad and paw swelling was chosen as a
read-out of lesiondevelopment. However, thismousepaw-infection
model of L. amazonensis has some important drawbacks because of
the parasite forms, their number, and the site used for infection.
Firstly, the inoculation of small numbers of L. amazonensismetacy-
clic promastigotes in the dermis of the ear results in much slower
disease progression (Courret et al., 2003). Secondly, L. amazonensis
paw lesions generally do not ulcerate, whereas inoculation into
the dermis of the rump region evolves as an ulcer (Soong et al.,
1997; Terabe et al., 2000), as often is observed in naturally infected
humans. We described the course of footpad infection in mice inoc-
ulated with smaller numbers of L. amazonensismetacyclics in com-
parison to the classical stationary-phase promastigotes infection
model; the patterns of partial resistance of C57BL/6 and susceptibil-
ity of BALB/c mice were maintained, but much longer lag phases
betweenmetacyclic inoculation and the onset of paw swellingwere
observed (Felizardo et al., 2007).
Because the several aforementioned factors might inﬂuence the
role of cytokines on the susceptibility to L. amazonensis infection,
we carried out the present study. We investigated the effects of
IL-4 deprivation and lack of signaling through the IL-4Ra-chain
on the resistance to L. amazonensis in C57BL/6 and BALB/c mice
infected with metacyclic forms in the footpad or in the rump.
2. Materials and methods
2.1. Animals
Interleukin-4-deﬁcient (IL-4/) andwild-type (WT) femalemice
(BALB/c and C57BL/6 background), 6–8 weeks old were obtained
from the breeding facilities of theDepartment of Immunology, Insti-
tute of Biomedical Sciences, University of São Paulo (ICB/USP). BALB/
c IL-4Ra/mice were kindly provided by Dr. Maria Ignes C.G. Elsas
(Dept. Pesquisa/Instituto Fernandes Figueira/FIOCRUZ-RJ, Rio deJaneiro, Brazil). All procedures involving animals were approved
by the ICB/USP Committee on ethical treatment of research animals.
2.2. Parasite
Leishmania (L.) amazonensis (WHOM/BR/75/Josefa) was kindly
provided by Dr. Elvira M. Saraiva (Dept. Immunology/UFRJ/Brazil).
Promastigotes forms were cultured in vitro at 25 C in Grace’s Insect
Cell Culture Medium (GIBCO-BRL Life Technologies, Grand Island,
NY, USA) supplemented with 20% heat-inactivated-FCS (GIBCO,
Argentina, South America), 100 U/ml penicillin (GIBCO-BRL) and
100 lg/ml streptomycin (GIBCO-BRL). Parasite infectivity was
maintained by passaging in BALB/c mice.
Puriﬁed metacyclic promastigotes were obtained from station-
ary-phase promastigote cultures by treatment with the 3A1-La
monoclonal antibody (hybridoma kindly provided by Dr. Elvira M.
Saraiva), which agglutinated the procyclic promastigotes
(Courret et al., 1999; Felizardo et al., 2007). Brieﬂy, stationary-phase
promastigotes from day 6 of culture were resuspended in PBS
(0.01 M phosphate-buffered, 0.15 M NaCl) to a concentration of
1  108/ml and incubated with 3A1-La monoclonal antibody
(mAb) (1:50) for 20 min at room temperature (RT). PBS was added
carefully and the suspension was centrifuged at 40g for 5 min at
RT. The supernatant containing 85–95% metacyclic forms was
collected and washed two times by centrifugation in PBS before
injection in the mice.
2.3. Infection of mice with L. amazonensis
Mice were inoculated subcutaneously with 1  104 puriﬁed
metacyclic promastigotes using a 25 Gauge needle into one of
the hind footpads or intradermally into the shaved skin of the
rump. The paw thickness and the diameter of the lesion in the
rump were monitored weekly using a metric calliper. Paw swelling
was calculated by subtracting the thickness of the uninfected con-
tralateral paw from that of the infected paw.
2.4. Quantifying parasites in the lesion and in lymph nodes
The parasite burden was estimated according to a previously
described limiting dilution method with minor modiﬁcations
(Lima et al., 1997). The injected paw or the rump skin lesions were
aseptically excised, weighed, homogenized and the cell suspen-
sions seeded in 96-well plates. The wells containing parasites were
scored using an inverted microscope and the data processed with
the ELIDA software program (Taswell, 1986). Differences between
two means were considered signiﬁcant when the means ± the
respective 95% conﬁdence intervals did not overlap.
It should be noted that these methods yielded estimates and not
the absolute numbers of parasites present in the original cell sus-
pensions. In fact, the serial dilutions of the parasite-containing tis-
sue homogenates and their subsequent culture may originate
estimates that signiﬁcantly exceed the number of parasites present
in the original tissue sample in spite of the care taken in perform-
ing the assays. In our experimental protocol, mice belonging to the
experimental and respective control groups were sacriﬁced on the
same day and the limiting dilution assays for the different organs
were run simultaneously, in order to minimize assay variations
and enable statistical analysis within the groups of mice on the
same day of infection.
2.5. Immunohistochemistry
The tissues were ﬁxed and embedded in parafﬁn according to a
previously published protocol (Beckstead, 1994) with minor mod-
iﬁcations. Brieﬂy, the tissues were ﬁxed in JB Fix solution (Tris
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serially dehydrated to 95% ethanol, incubated in isopropyl alcohol
followed by immersion in Clarus EcoK (non-toxic aliphatic hydro-
carbon, Clarus Technology, Brazil) and parafﬁn embedding. The
3 lm-thick sections were unwaxed at 56 C, immersed in Clarus-
EcoK and hydrated. After blocking with Super Block buffer (Pierce
Chemical Co., USA) the sections were incubated with anti-Leish-
mania mouse serum, washed and stained with FITC-labelled
goat-anti-mouse Immunoglobulin antibody. The nuclei were
stained with 4,6-diamidino-2-phenylindole (DAPI, Sigma, St. Louis,
MO) and the slides mounted in anti-fading mounting media
(Vectra-Shield, USA).
The images were captured using a Nikon ﬂuorescence micro-
scope coupled to Image-Pro Plus software (kindly made available
by Dr. Telma Tenorio Zorn, Department of Cell Biology, ICB/USP).
2.6. Treatment in vivo with anti-IL-10 Receptor antibody
Interleukin-4-deﬁcient C57BL/6 mice were treated with anti-IL-
10 receptor mAb (1B1.3A) or with the isotype control mAb
(GL117.41, anti-b-galactosidase) beginning on the 22nd week of
infection. One mg was injected intraperitoneally (i.p.) every three
days for two weeks. Anti-IL-10R mAb and the isotype control
mAb were puriﬁed in our laboratory from hybridomas kindly pro-
vided by DNAX Research Laboratories, Palo Alto, CA, USA.
The biologic activity of 1B1.3A mAb was determined by its abil-
ity to enhance LPS-induced septic shock. C57BL/6 mice were in-
jected i.p. with 2 mg or 1 mg of 1B1.3A mAb 24 h before
receiving i.p. a sub-lethal (500 lg) dose of LPS. All mice treated
with 1B1.3A and challenged with LPS died in the next 48 h, while
all mice inoculated with isotype control mAb survived.
2.7. Cytokine production by lymph node cells in culture
Cell suspensions from the draining LNs (popliteal or inguinal)
were resuspended in RPMI-1640 supplemented with 5% heat-inac-
tivated FCS and antibiotics and seeded at 5  106 cells/ml in
24-well-plates. Cells were cultured in the presence of live L. ama-
zonensis promastigotes (1  106/ml) at 37 C for 72 h. The superna-
tants were assayed by two-site sandwich ELISA for IL-10, IL-13, and
IFN-c as previously described (Abrahamsohn and Coffman, 1995).
Antibodies and cytokine standards were purchased from Biosci-
ences Pharmingen (Becton Dickinson Co) (IL-10 and IFN-c) or
R&D Systems (IL-13). Streptavidin-horseradish peroxidase was
purchased from Southern Biotechnology Associates Inc., AL, USA.
The reaction was developed by ABTS reagent and the optical den-
sities were read in an automatic microplate reader (Versa Max,
Molecular Devices). Cytokine concentrations were determined
from standard curves generated from recombinant cytokines.
2.8. Statistical analyses
The data were analyzed by repeated measures analysis of vari-
ance (ANOVA) using INSTAT 2 software. Differences were consid-
ered signiﬁcant when p < 0.05.Fig. 1. Lesion development in wild-type (WT) and IL-4/ BALB/c and C57BL/6 mice
inoculated into the footpad or rump in the rump with L. amazonensis. The mice were
inoculated with 104 L. amazonensis metacyclics into the dermis of one of the rear
footpads (A) or the rump (B). Paw swelling in A is expressed by the difference in
thickness between the inoculated and uninoculated paw. Lesion diameter in B is the
diameter of the ulcer or of the indurated area (when no ulcer exists) at the site of
inoculation. Ulceration of rump lesions occurred in BALB/cmice (WT and IL-4/) and
inWTC57BL/6mice as indicatedby the vertical arrow. Rump lesions in IL-4/C57BL/
6 mice did not ulcerate. The means ± SEM of three independent experiments (6 mice
each) are presented. Signiﬁcant differences between WT BALB/c and IL-4/ BALB/c
occur fromday 11 on, inA and fromday 6 on, inB; forWTC57BL/6 vs. IL-4/ C57BL/6
they are indicated with ⁄ in A and occur from day 6 on, in B.3. Results
3.1. Course of infection by L. amazonensis in wild type and in IL-4/
BALB/c and C57BL/6 mice inoculated into the footpad or rump
BALB/c or C57BL/6 mice inoculated into the footpad with
L. amazonensis metacyclic forms developed paw swelling without
ulceration (Fig. 1A). Paw swelling in BALB/c mice increased from
week 7 of infection, reaching 11 mm (approximately sevenfoldthicker than a normal paw (1.5–1.7 mm) by week 24. Paw swelling
in relatively resistant C57BL/6 mice also started on week 7 of infec-
tion, slowly increasing to a maximum of approximately 2 mm by
week 15, followed by sharp decrease around week 17. Thereafter
the lesion maintained itself as a persistent indurate swelling of
about 0.8–0.9 mm that did not heal (Fig. 1A).
In comparison to BALB/c mice, BALB/c IL-4/ inoculated in the
footpad, had signiﬁcantly smaller and slower progressing lesions,
reaching 4 mm by week 24 (Fig. 1A). However, the difference in
paw sizes between C57BL/6 IL-4/ mice and their WT counter-
parts was less striking: it was evident between weeks 14 and 17
of infection and became non signiﬁcant thereafter (Fig. 1A). It is
important to mention that even in C57BL/6 IL-4/ mice the paw
lesion did not completely regress and was still present until week
48 of infection (maximum time of observation).
Taken together, these results indicate that for the footpad mod-
el of L. amazonensis infection: (a) C57BL/6 mice were more resis-
tant than BALB/c mice but were unable to completely heal the
paw lesion; (b) IL-4 is an important susceptibility factor for
Table 1
Dissemination of L. amazonensis from footpad and rump inoculation sites to distant lymphoid organs in d-type C57 Wild Type and in IL-4/ BALB/c and C57BL/6 mice.
BALB/c C57BL/6
Organ parasitism after footpad inoculation Organ parasitism after footpad inoculation
ING-il AXI-il POP-cl ING-cl AXI-cl Iliac Spleen ING-il AXI-il POP-cl ING-cl AXI-cl Iliac Spleen
WT 3 wk nd nd nd nd nd nd nd WT 3 wk + nd nd nd nd nd +
13 wk ++ nd ++ nd nd ++ ++ 13 wk + + + + + ++ +
24 wk +++ ++ + nd nd ++ +++ 24 wk nd + ++ + + + +
IL-4/ 3 wk nd nd nd nd nd nd nd IL-4/ 3 wk nd nd nd nd nd nd nd
13 wk nd nd + nd nd ++ ++ 13 wk + nd + nd nd + +
24 wk nd nd nd nd nd nd nd 24 wk + nd nd nd nd + +
Organ parasitism after rump inoculation Organ parasitism after rump inoculation
AXI-r AXI-l POP-r POP-l Iliac Spleen AXI-r AXI-l POP-r POP-l Iliac Spleen
WT 3 wk nd nd nd nd nd nd WT 3 wk nd nd nd nd + nd
13 wk nd nd nd nd + + 13 wk + + + + ++ +
24 wk +++ ++ ++ +++ +++ +++ 24 wk + + + + + +
IL-4/ 3 wk nd nd nd nd nd nd IL-4/ 3 wk nd nd nd nd nd nd
13 wk nd nd nd nd nd nd 13 wk nd nd nd nd + nd
24 wk nd nd nd nd nd nd 24 wk nd nd nd nd + nd
Organ abbreviations: ING (inguinal lymph node), il (ipsilateral), AXI (axillary lymph node), r (right side), l (left side), POP (popliteal lymph node), cl (contralateral), Iliac (iliac
lymph nodes).
The mice were infected with 104 metacyclic forms. The number of parasites in the organs was estimated by a limiting dilution assay (LDA) on the 3rd, 13th and 24th weeks
after infection. Data were analyzed by ELIDA software; the mean was calculated from six individual mice. The results are shown as intensity of parasitism: nd (not detected);
+ (6101 parasites); ++ (102–103 parasites); +++ (P103 parasites).
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tenance of the lesion; (c) IL-4 is not the factor maintaining the par-Fig. 2. Lesions and parasite distribution in the skin of WT C57BL/6 and IL-4/
C57BL/6 mice on the 24th week after inoculation in the footpad or rump with L.
amazonensis. The minimal lesion in the paw and the absence of macroscopic lesion
in the rump of IL-4/ C57BL/6 mice contrast with the large ulcerated lesion in the
rump of a WT C57BL/6 mouse. Photomicrographs (magniﬁcation 200) show that
parasites stained by indirect immunoﬂuorescence are present mainly in the dermis
underlying the lesions and also in the epidermal layer of the seemingly normal skin
of the rump inoculation site in IL-4/ C57BL/6 mice. Arrows indicate the lesion and
point to some of the stained parasites in the tissue sections.tial susceptibility of C57BL/6 mice, because the lack of IL-4 neither
led to complete regression of the paw lesion (cf. Fig. 1A) nor to par-
asite elimination (cf. Fig. 3 and Table 1).
Strikingly different results were obtained when mice were
infected in the dermis of the dorsal skin of the animals’ rump re-
gion with L. amazonensis metacyclics. Firstly, the time-lag
(6 weeks) for lesion appearance, progression and size were very
similar for WT BALB/c and WT C57BL/6 mice until week 16–17.
Thereafter, the lesions grew more rapidly in WT BALB/c than in
WT C57BL/6 mice, so that by the 24th week of infection they were
about 25% larger than those seen in WT C57BL/6 mice. In WT mice
of either strain the rump lesion became ulcerated and extended
deep into the dermis (Fig. 1B). Secondly, C57BL/6 IL-4/ mice
did not develop any lesion at the rump inoculation site (Fig. 1B).
In contrast BALB/c IL-4/ developed a slowly-growing shallow
ulcerated lesion from week 10 of infection, although much smaller
than that developing in WT BALB/c mice.
The macroscopic aspect of the lesions in WT C57BL/6 and in
C57BL/6 IL-4/ mice infected in the footpad or in the rump skin
and the parasite density in sections of the lesions are shown in
Fig. 2. The less intense parasitism of the rump lesions in compari-
son with the footpad lesions can be seen in the tissue sections
stained for parasites by immunoﬂuorescence (Fig. 2). Although
rump-inoculated C57BL/6 IL-4/ mice did not develop any lesion
at the inoculation site, the biopsies showed parasites, more often
found in the epidermal layer and upper dermis. In comparison,
WT C57BL/6 mice had many more parasites located in the deeper
dermis of the ulcerated lesion in the rump (Fig. 2).
The overall aspect of the paw and rump lesions in BALB/c mice
was similar to those in WT C57BL/6 mice but paw swelling was
more pronounced and the dorsal skin ulcers were larger and dee-
per (data not shown). The infected paws of BALB/c IL-4/ mice
were indurated and swollen to a similar extent as those from
C57BL/6 mice, only much thicker (data not shown).3.2. Parasitic load and dissemination of L. amazonensis in wild-type
and in IL-4 deﬁcient BALB/c and C57BL/6 mice
The parasite burden was estimated by LDA in the lesion and the
corresponding draining lymph node (LN): popliteal for the
52 T.C. Felizardo et al. / Experimental Parasitology 130 (2012) 48–57footulated mice and superﬁcial inguinal for the rump-inoculated
mice (Fig. 3). Parasite dissemination to distant LNs and to the spleen
was also inspected at different times after infection (Table 1).
In general, parasite numbers per 10 mg of tissue were smaller in
material taken from the dorsal skin lesions than from footpadFig. 3. Parasitic load in the inoculation site and in the draining lymph nodes (LN) fromW
and D) were inoculated into the footpad or rump with 104 L. amazonensismetacyclic form
parasites were estimates obtained by LDA followed by ELIDA analysis for the inoculation
and D), popliteal and superﬁcial inguinal. Results are the means of six or seven individu
IL-4/ are indicated by⁄.tissue, as shown in Fig. 3A for either WT or IL-4/ C57BL/6 mice,
and in Fig. 3C for WT or IL-4/ BALB/c mice. The photomicro-
graphs of parasite-stained footpad sections in comparison with
dorsal skin sections shown in Fig. 2 also illustrate the lesser para-
sitism of the latter.T and IL-4/ BALB/c and C57BL/6 mice. C57BL/6 mice (A and B) and BALB/c mice (C
s. Quantifying parasites was done by a limiting dilution assay (LDA). The numbers of
sites, footpad or rump lesion (A and C), and the respectively direct draining LNs (B
al mice and the 95% conﬁdence intervals. Signiﬁcant differences between WT and
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asite load is that there is no direct correlation between size of le-
sion and the number of parasites. This point is exempliﬁed by
WT BALB/c and BALB/c IL-4/ mice whose paw swelling data
showed a threefold difference (cf. Fig. 1A) despite comparable par-
asite loads (Fig. 3C). Moreover, there was no correlation of parasite
load with the size of the skin lesion of the rump or the extent of
ulceration; the size of the lesion and the subsequent ulceration
are similar for WT BALB/c and WT C57BL/6 (cf. Fig. 1B). However,
the parasite load in the latter is lower by a factor of eight orders
of magnitude (cf. Fig. 3A WT C57BL/6 mice vs. Fig. 3C WT BALB/c).
Importantly, C57BL/6 IL-4/ mice inoculated in the rump, that
did not develop any lesions, still harbored a small number of par-
asites (about 10 or less) at the site of inoculation (Fig. 3A) and also
had parasites in the inguinal draining LN throughout the infection
(Fig. 3B). At most time points in both mouse strains, the numbers
of parasites in the lesion and in the draining LN were smaller for
IL-4/ mice compared to WT controls. However, this was not
the case for BALB/c mice inoculated in the footpad until 13 weeks
of infection (Fig. 3C-footpad parasite load; 3 and 13 weeks) and the
corresponding popliteal LN (Fig. 3D).
Dissemination of parasites from the footpad or rump site
occurred in both susceptible and resistant mice. Several lymphoid
organs were parasitized throughout the infection and heavier
parasitic load was found inWTmice (Table 1). Systemic dissemina-
tion of parasites by the blood was observed from the 13th week of
infection and occurred in footpad-inoculated WT and BALB/cFig. 4. Cytokine production in WT and IL-4/ C57BL/6 mice. Mice were infected in the fo
incubated with live promastigotes as a secondary in vitro stimulus or maintained only
amounts of IFN-c IL-10 and IL-13 were determined by ELISA. Means and SEM of three ind
inguinal lymph nodes are indicated by ⁄.IL-4/mice as well as in rump-inoculated WT BALB/c mice (Table
1). However, for those BALB/c IL-4/ mice infected in the skin of
the rump, parasites were only found in the lesion-draining inguinal
LN (Table 1 and Fig. 3). In comparison, WT C57BL/6 mice, whether
inoculated in the footpad or in the rump, had disseminated para-
sites by the blood route to the spleen or iliac LN already on the third
week of infection (Table 1). Parasitism of distant organs in C57BL/6
IL-4/mice was detected later (13 weeks) than in the WT controls
and could be observed in either footpad- or in rump-inoculated
mice (Table 1).
Summarizing for the rump skin model of infection by L. amazon-
ensis: (a) C57BL/6 mice developed progressive ulcerated lesions as
did BALB/c mice but eventually demonstrated better control of par-
asitism; (b) IL-4 is an important susceptibility factor for BALB/c
mice; however, other factors are signiﬁcant, because BALB/c
IL-4/ mice still developed an ulcer with heavy parasitism; (c)
IL-4 is a major susceptibility factor for C57BL/6 mice because
C57BL/6 IL-4/ mice did not develop any detectable lesions at
the inoculation site in the dorsal dermis, although parasites were
present in low numbers in the skin and draining LNs.
3.3. Production of cytokines in lymph node cell cultures from wild type
and IL-4/ C57BL/6 mice
Cytokines were quantiﬁed in supernatants obtained from
draining LN cell cultures obtained from WT and IL-4/ C57BL/6
mice inoculated in the footpad or rump with L. amazonensis. Theotpad or rump with L. amazonensismetacyclics, and cells from the draining LNs were
in culture medium for 72 h before supernatant removal for cytokine testing. The
ependent experiments are presented; signiﬁcant differences between popliteal and
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C57BL/6 mice was of interest because IL-4/ C57BL/6 mice, when
inoculated in the rump, harbor parasites but do not develop lesions
and when inoculated in the footpad develop small persistent indu-
rated lesions with more parasites in both the lesion and draining
LN (cf. Fig. 3A).
As expected, parasite-stimulated LN cultures from IL-4/mice,
whether infected in the footpad or the rump, had much higher
levels of IFN-c in comparison to WT mice (Fig. 4). Compared to
the respective C57BL/6 WT controls, IFN-c production was higher
in popliteal than in inguinal LNs.
Interleukin-10 production levels in LN cultures in general were
higher for WT than for IL-4/ mice, except on week 10 after foot-
pad infection (Fig. 4). Production of IL-10 by the draining LN of WT
mice inoculated in the footpad was higher than in the cultures
from WT mice inoculated in the rump.
Signiﬁcant levels of IL-13 were measured in LN cultures from
infected WT C57BL/6 mice but there were no signiﬁcant differ-
ences in the amount of IL-13 produced by cultures from footpad-
inoculated and rump-inoculated mice. As expected, IL-13 levels
were very low in cultures from IL-4/ mice (Fig. 4). There were
no signiﬁcant differences between IL-12 levels measured in LN cul-
tures from WT and C57BL/6 IL-4/ mice (data not shown).
In order to testwhether the low IL-10 levels observed in the LN of
rump-inoculated C57BL/6 IL-4/ mice were contributing to the
maintenance of parasitism, groups of thesemicewere treated (start-
ing on the 22nd week of infection) systemically with anti-IL-10R or
with isotype control antibodies for two weeks. At the end of treat-
ment, parasites were quantiﬁed in tissue of the inoculation site
and draining LN. No signiﬁcant differences in the number of para-
sites were seen between the two groups (data not shown). This re-
sult suggests that cytokines other than IL-10 may be involved in
the maintenance of residual parasitism in IL-4/ C57BL/6 mice.
3.4. Course of L. amazonensis infection in wild-type and IL-4-receptor-
a/ BALB/c mice
The data so far described indicate that an important share of
BALB/c susceptibility to L. amazonensis is IL-4-independent. We
proceeded to investigate the effects of the lack of signaling by
IL-4 and IL-13 on the footpad and rump infection models. Foot-
pad-infected BALB/c IL-4Ra/ mice had signiﬁcantly less paw
swelling when compared to WT BALB/c (Fig. 5A) and IL-4/ mice
(cf. Fig. 1); mean increase in thickness was about 2 mm and per-
sisted from week 12–24 of infection. However, the parasite bur-
dens in the paw (1010) (Fig. 5B) and the popliteal LN (109)
(Fig. 5C) were still high by the 24th week of infection and similar
to those in BALB/c IL-4/ mice (Fig. 3).
In contrast, when injected in the rump skin, only 30% of BALB/c
IL-4Ra/ mice developed a small indurated lesion (Fig. 5A) that
did not ulcerate and was signiﬁcantly smaller than the lesions in
similarly infected BALB/c IL-4/ mice infected by the same route
(cf. Fig. 5 vs. Fig. 1). Only thoseBALB/c IL-4Ra/mice thatdeveloped
a lesionhadparasites at the inoculationsite; thenumberswere com-
parable to those found in lesions from BALB/c IL-4/mice (Fig. 5B
vs. Fig. 3C). Although the directly draining inguinal LN (Fig. 5C)
was free of parasites, when other LNswere screened, parasites (esti-
matedas less than10)were foundon the2ndweekof infection in the
popliteal LN from the right and left leg indicating spread of the infec-
tion; all other distant lymphoid organs examined were free of para-
sites until the 24th week of infection (data not shown).4. Discussion
Our results show that the site where L. amazonensis is inocu-
lated in the mouse skin determines the type and development ofthe lesion as well as the extent to which it is affected by the cyto-
kines IL-4 and IL-13.
Inoculation in the footpad resulted in signiﬁcantly less paw
swelling forWT C57BL/6mice in comparison withWT BALB/c mice,
conﬁrming the relative resistance of the former mouse strain to
L. amazonensis infection. In contrast, after intradermal inoculation
of L. amazonensis into the skin of the rump, both WT C57BL/6 and
WT BALB/c mice developed single progressive ulcerated lesions of
comparable size until the 17th week of infection; thereafter the le-
sion continued to grow at a slower pace in C57BL/6 mice than in
BALB/c mice. In spite of the rapidly growing ulcer, C57BL/6 mice
controlled the local and systemic parasite load well, whereas
BALB/c failed to do so (cf. Figs. 1B, 3 and Table 1). The inﬂuence of
the inoculation site on pathogenesis had already been shown for
some species of Leishmania (Nabors and Farrell, 1994; Poulter and
Pandolph, 1982). For instance, L. major infections of DBA/2 mice,
which are highly resistant when infected in the ear pinna but devel-
op progressive lesions when inoculated at the base of the tail (Bald-
win et al., 2003). Our results stress the dissociation between size of
lesion and parasitic load and the inﬂuence of the inoculation site on
these two parameters in the infection caused by L. amazonensis.Our
results showing similar lesion growth in L. amazonensis metacyc-
lics-rump-infected WT C57BL/6 and WT BALB/c mice differ from a
previous report in which the lesion in WT C57BL/6 was at eight
weeks of infection threefold smaller than in BALB/c mice; however,
the inoculum used was 106 amastigotes injected in the base of the
tail (McMahon-Pratt and Alexander, 2004).
We found that ulcerations occurred only in rump lesions and
never in the infected paws, even when they became intensely in-
ﬂamed as in BALB/c mice. Infection severity and the appearance
of ulcerative lesions in the footpad inoculation model of L. amazon-
ensis infection correlated with the presence of TCD4+ cells (Silva
et al., 1994; Soong et al., 1997). In fact, infected SCID C.B-17 mice
developed nodular non-ulcerative lesions which ulcerated after
transfer of WT TCD4+ spleen cells, conﬁrming the involvement of
this cell population in the pathogenesis of the ulcerative process
(Terabe et al., 2000). It must be considered that in the footpads
the epithelium and the dermis are much thicker than in the hairy
skin and that the subcutaneous tissue has denser connective tissue
and adipocytes lying in continuity with the muscle layer and bone.
In contrast, the subcutaneous tissue of the rump region is thin and
loosely attached to the underlying muscle. Most likely, inﬂamma-
tion, collagen synthesis, and wound repair run distinct courses in
the paw and in the hairy skin. Recently, differential expression of
the gene Fli1 that controls wound healing has been correlated to
susceptibility to L. major infection (Sakthianandeswaren et al.,
2010). Furthermore, Langerhans cells, which do not seem to have
an equal distribution in the skin across the body (discussed in Kirk-
patrick et al., 1987) also have been associated to L. major infection.
This subset of dendritic cells promotes an expansion of speciﬁc-T
regulatory cells which turns into suppression of Th1 immunity
(Kautz-Neu et al., 2011).
Besides the structural aspects, cytokine production in L. major-
infected CB6F1 mice inoculated in the footpad was shown to be
predominantly Th1 with high IFN-c levels, or Th2 with IL-4 and
lower IFN-c when inoculation was performed in the dorsal skin
(Nabors et al., 1995). Our results with L. amazonensis did not show
such differences: in fact, IL-4 production by LN cells draining the
paw or the rump lesion was low, whereas IL-10 and IFN-c produc-
tion were generally higher in the popliteal LN than in the inguinal
LN. Yet, in general, mice infected in the rump were better able to
control the parasite load, possibly because of lower IL-10
production.
The lesions of BALB/c mice were signiﬁcantly smaller in IL-4/
mice in comparison with WT mice. However, rump-infected
IL-4/ BALB/c efﬁciently controlled local parasitism but such local
Fig. 5. Lesion development and parasitic load in the inoculation site and regional lymph nodes of WT BALB/c mice and of IL-4Ra/ BALB/c mice infected with L. amazonensis
in the footpad or in the rump. The mice were inoculated with 104 L. amazonensis metacyclic forms and the footpad and rump lesions (A) were measured as described in the
legend to Fig. 1. Ulceration of the lesion in rump-inoculated mice is indicated by vertical arrow. Parasites were quantiﬁed (B) in the inoculation site and its draining lymph
nodes. Popliteal and inguinal lymph nodes (C) correspond to the draining organs of footpad and rump, respectively. Parasite quantiﬁcation was done by limiting dilution assay
(LDA) and analyzed by ELIDA software. The values obtained were estimates of parasite numbers. Results represent the means of six or seven individual mice and 95%
conﬁdence intervals. Signiﬁcant differences between WT and IL-4Ra/ are indicated by⁄.
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C57BL/6 mice IL-4 was also a more important susceptibility factor
when inoculation was done in the rump skin than in the footpad
because footpad inoculated IL-4/ C57BL/6 mice still had small,
persistent lesions with high parasite load whereas rump-inocu-
lated mice did not have any local lesion and less than 10 parasitesin biopsies of the inoculation site. Our ﬁndings that in the C57BL/6
paw infectionmodel the lack of IL-4 only partially reduced swelling
and parasite load, agree with those obtained by other authors
(Jones et al., 2000; McMahon-Pratt and Alexander, 2004). There-
fore, the relative importance of IL-4 as a determinant of susceptibil-
ity differs according to the inoculation site. Unexpectedly, IFN-c
56 T.C. Felizardo et al. / Experimental Parasitology 130 (2012) 48–57production by popliteal LN cells was higher than by inguinal LN
cells. Nevertheless, in L. amazonensis infection, IFN-c may either
control or favor amastigote multiplication depending on its associ-
ation with stimuli such as LPS or TNF-a (Qi et al., 2004).
With respect to IL-10, we treated footpad- or rump-infected
C57BL/6 IL-4/ during the chronic phase of infection with anti-
IL-10R mAb Asc-1B1 and observed no effect on the lesion or on
proximal or distant LN parasitic loads. However, previous work
on the role of IL-10 in L. amazonensis infections yielded controver-
sial results (Ji et al., 2003; Jones et al., 2002; Padigel et al., 2003).
Parasite strain differences are important in this context as was
clearly shown for L. major strains, whose susceptibility to IFN-c-
activated macrophages is markedly diverse (Noben-Trauth et al.,
2003).
Another Th2-type cytokine involved in the susceptibility to
Leishmania infections is IL-13. The joint participation of IL-13 and
IL-4 as susceptibility factors to L. major has been documented in
several studies which analyzed the role of IL-13 alone (Matthews
et al., 2000) or investigated the course of infection in IL-4Ra/
mice lacking signaling through both IL-4 and IL-13 (Mohrs et al.,
1999; Nagase et al., 2007; Noben-Trauth et al., 2003; Radwanska
et al., 2007). In order to investigate the role of IL-13 in susceptibil-
ity to L. amazonensis we compared the course of infection in IL-
4Ra/ BALB/c to IL-4/ and WT mice of the same strain. In agree-
ment with previous work (Guimaraes et al., 2006), our results
(Fig. 1A and B) showed only partial control of infection in L. ama-
zonensis footpad-infected IL-4/ BALB/c mice. However, the lack
of signaling by IL-4 and IL-13 had a marked effect at reducing
paw swelling in IL-4Ra/ mice, but did not reduce parasitism in
the lesion and the draining LN in comparison with IL-4/ BALB/c
mice (cf. Fig. 5 vs. Fig. 1A and Fig. 3). Most important is that after
parasite inoculation in the rump, only 30% of BALB/c IL-4Ra/
mice became infected. Thus, IL-13 plus IL-4 had a more important
role in determining susceptibility to L. amazonensiswhen the infec-
tion was performed in the dorsal skin than in the footpad. Compar-
ing these results with those of IL-4/ on the C57BL/6 background,
which also fail to develop a lesion when inoculated in the rump, we
can consider that elimination of only IL-4 would be sufﬁcient to
avoid lesion and reduce the parasitism in C57BL/6 mice. By con-
trast, neutralization of both IL-4 and IL-13 would be required to ob-
tain a similar result in susceptible BALB/c mice. However, innate
immunity factors such as the wound repair response may also play
a pivotal role in the resistance to L. amazonensis as described for a
group of genes in murine L. major infection (Sakthianandeswaren
et al., 2005).
These ﬁndings indicate that IL-4 and IL-13 have a critical impor-
tance in the susceptibility to L. amazonensis infection. In addition,
the inoculation site and consequently the type of lesion are impor-
tant factors in the pathogenesis of cutaneous leishmaniasis.
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